Glycated Albumin Monitoring

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 100

Sponsor: Washington University School of Medicine

Location: Washington University - Core Laboratory for Clinical Studies St Louis Missouri

Summary

The goal of this observational study is to learn if the short-term glucose marker (glycated albumin) works as well or better than CGM and/or hemoglobin A1c to indicate to providers that a change in medication is working to improve patient's blood sugar control. Participants will have a blood draw at baseline (when their provider is making a change in medication to treat their diabetes) and also every 4 weeks until the next provider visit. At the end of the study, researchers will compare the time (days, weeks) to see a change in blood glucose control with each of the markers. Participants will be enrolled for up to one year.

Eligibility Criteria

Inclusion Criteria: * diabetes diagnosis * currently using a CGM Exclusion Criteria: * persons with cirrhosis, nutritional deficiencies, or hypoalbuminemia * pregnant persons

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07777900). StuddyBuddy aggregates publicly available trial information.